Notification of Interim Results

RNS Number : 8292J

Futura Medical PLC

13 August 2012

 



For immediate release

13 August 2012

 

 

Futura Medical PLC

("Futura" or the "Company")

Notification of Interim Results

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, will announce its interim results for the six months ended 30 June 2012 on Tuesday 11 September 2012.

A briefing for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan, 107 Cheapside, London, EC2V 6DN.

For more information, or to register attendance, please contact Buchanan on 020 7466 5000.

For further information:

Futura Medical plc	+ 44 (0) 1483 685 670
James Barder, Chief Executive Officer
Mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited	+ 44 (0) 20 7776 1200
Phil Walker / Giles Balleny
Buchanan	+ 44 (0) 20 7466 5000
Mark Court / Fiona Henson / Sophie Cowles

Notes to editors:

About Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare.  The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com 

 

END

 

 

NOREAKPEFDFAEFF